Ardent Health ($ARDT) Discloses Revenue Overstatement and Liability Exposure Case

M.D. Tennessee

Court

3:26-cv-00022

Case number

07/18/2024

Class period Start

11/12/2025

Class period End

03/09/2026

Lead Plaintiff motion deadline

$ARDT investors filed a claim against Ardent Health Inc. for allegedly misrepresenting the reliability of its revenue estimates and failing to disclose known issues with its accounts receivable assessments and malpractice liabilities.
After announcing a $43 million revenue adjustment, a sharp increase in liability reserves, and a cut to EBITDA guidance, $ARDT fell 34% from $14.05 on November 12, 2025, to $9.30 on November 13, 2025.
$ARDT investors can join this case to be notified about potential recovery.
Case Details:

Between its IPO in August 2025 and November 2025, Ardent Health told investors that its revenue recognition and bad debt reserves were based on consistent, historical collection patterns and detailed financial analysis. The company also stated that it maintained adequate medical malpractice reserves, adjusting them based on claims history and actuarial analysis.

However, Ardent later admitted that its methodology relied on a 180-day cutoff for assessing collectability, rather than the more comprehensive process previously described. This issue became apparent after implementing a new accounting system, which revealed that prior assumptions significantly overstated expected revenues.

On November 12, 2025, Ardent announced a $43 million downward revision in net revenue due to collectability reassessments and a $54 million increase in malpractice liability reserves, citing rising litigation risks and loss trends in New Mexico. The company also cut its EBITDA guidance by nearly 10%.

The following day, November 13, 2025, $ARDT fell 34%, closing at $9.30, down from $14.05, erasing substantial shareholder value.

Based on these events, $ARDT investors filed a claim against Ardent Health, alleging the company:
It misrepresented the reliability of its accounts receivable and revenue estimates.
It failed to disclose risks tied to outdated or inadequate collection assumptions.
It understated liability exposure related to malpractice claims and industry trends.
Investors argue Ardent provided misleading assurances about financial stability and reserves, leading to significant losses when the truth was revealed.

Case Type

US Securities Class Action

Case Status

Lead Plaintiff Appointment

Alleged Offence

Misleading Statements,

Financial Misrepresentation,

Failure to Disclose

Suspected Party

Directors,

Management

Security Type

Stocks

Trade Direction

Long

Shock Event Date

11/12/2025

Filing date

01/07/2026

Lead Plaintiff Deadline

03/09/2026

Trusted by industry leaders

Endorsed by top professionals who trust our innovative solutions to drive impactful results.